Guide

Top 4 current economic challenges faced by biopharma companies

With the dynamic nature of the current economic climate, biopharma companies must seek out strategic solutions to maximize the value of their investments and enhance communications with HCDMs. This article details challenges and provides potential solutions. Fill out the form below to download the report.

Related resources

Article

AI-powered tools for pricing: Key takeaways from ISPOR Europe 2025

Article

Rethinking oncology launches: How the next generation of patients is reshaping strategies

Article

The transformative potential of AI in supporting health economic modeling

We’re here to help

Connect with our team today to learn more about how Cencora is helping to shape the future of healthcare.